# V1 Empirics Check — qwen/qwen3.5-397b-a17b (Variant C)

**Model:** qwen/qwen3.5-397b-a17b
**Variant:** C
**Date:** 2026-03-22T16:36:01.811077

---

# Review of "The Missing Emergency Room Tax: GP Practice Closures and A&E Utilization in England"

## 1. Idea Fidelity

The paper largely pursues the original idea manifest but deviates significantly on the critical econometric strategy. The manifest proposed a **Callaway-Sant'Anna (CSA)** staggered event study to handle the heterogeneous timing of 1,400+ GP closures. The paper, however, employs a standard **Two-Way Fixed Effects (TWFE)** estimator, noting only that CSA was "attempted." This is a substantial downgrade in identification rigor, particularly given the data structure. Additionally, the manifest cited ~1,400 closures, while the paper reports 2,464; while data updates are acceptable, the shift from CSA to TWFE undermines the manifest's core promise of causal credibility in a staggered setting. The research question (GP closure → A&E utilization) and data sources (NHS ODS, A&E statistics) remain faithful to the original proposal.

## 2. Summary

This paper estimates the causal effect of GP practice closures on Type 1 Emergency Department (A&E) attendances in England using a panel of 122 NHS trusts from 2017 to 2025. The authors find a statistically insignificant 3.2% increase in attendances overall but identify a significant 6.6% increase in the post-COVID period (2022–2025). The central contribution is the claim that the "emergency room tax" of primary care consolidation is conditional on system capacity, emerging only when the NHS is strained.

## 3. Essential Points

The authors must address three critical issues before this paper can be considered credible for publication:

1.  **Universal Treatment Bias:** The paper states that **119 of 122 trusts are eventually treated**. In a staggered DiD setting, TWFE estimators are known to be biased when there are few or no never-treated controls (De Chaisemartin & Ferrer, 2020). The TWFE coefficient relies on comparing early-treated to late-treated units, which imposes negative weighting on later effects if treatment effects are heterogeneous. With almost no control group, the TWFE estimate is likely biased, and the standard errors do not correct this bias. The manifest's proposed CSA estimator is required here to avoid this pitfall.
2.  **Treatment Definition Aggregation:** The binary treatment indicator switches on after *"any* GP practice within 10 km closes." This collapses the staggered variation. If a trust experiences five closures over five years, the indicator switches on once and stays on. This conflates the effect of the first closure with the cumulative effect of subsequent closures, destroying the power of the staggered design proposed in the manifest. The estimator cannot distinguish between the marginal effect of one closure versus five.
3.  **Post-COVID Identification:** The significant post-COVID result (6.6%) is vulnerable to confounding. By 2022, nearly all trusts are treated. The "Post-COVID" effect effectively compares late-treated trusts to early-treated trusts during a period of systemic shock. Without a clean control group or a robust event study showing parallel trends *within* the post-COVID window, this result may reflect general A&E surge trends rather than a causal closure effect.

## 4. Suggestions

To elevate this paper from a descriptive correlation to a credible causal inference suitable for *AER: Insights*, the following econometric and structural improvements are necessary. These suggestions constitute the bulk of the required revision work.

### Econometric Specification and Identification
The most urgent fix is returning to the **Callaway-Sant'Anna (CSA)** or **Interaction-Weighted (IW)** estimator proposed in the manifest. With 119/122 trusts treated, the "never-treated" group is too thin for standard DiD. The CSA estimator allows you to use "not-yet-treated" units as controls for each specific treatment cohort. This avoids the negative weighting problem inherent in TWFE when treatment effects are heterogeneous over time.
*   **Action:** Re-run the main table using `did` (Stata) or `did` (R) packages implementing CSA. Report the group-time average treatment effects.
*   **Action:** If CSA fails due to lack of controls (i.e., all units treated too quickly), consider an **exposure-weighted** design where the treatment intensity is continuous (e.g., number of closures per capita) rather than binary. This allows variation even when all units are "treated" to some degree.

### Treatment Intensity and Dosage
The current binary indicator ("Post-Closure") is too coarse. A closure of a 5,000-patient practice is not equivalent to a closure of a 15,000-patient practice. The manifest highlighted "patient list growth at surviving practices" as a mechanism; the paper ignores this in the main specification.
*   **Action:** Construct a **dose variable**: $\text{Treatment}_{it} = \sum \text{Patients Displaced}_{it} / \text{Trust Population}_{it}$. This captures the shock size rather than just the occurrence.
*   **Action:** Test for **cumulative effects**. If Trust A has 3 closures and Trust B has 1, the binary indicator treats them identically after the first closure. Use the "Cumulative Closures" variable (Column 5) as the *primary* specification, not a robustness check. The current negative coefficient on intensity (-0.001) suggests model misspecification—likely due to the TWFE bias discussed above.

### Geographic Granularity
NHS Trusts are large administrative units. A GP closure 10km from a Trust's main hospital might be 40km from the patients actually served by that hospital. Trust-level aggregation introduces noise.
*   **Action:** If possible, move the unit of analysis to **Lower Layer Super Output Areas (LSOAs)** or **Clinical Commissioning Groups (CCGs/ICBs)**. These are smaller and align better with GP catchment areas.
*   **Action:** If Trust level is retained, refine the distance metric. Use **patient flow data** (if available via NHS England) to weight closures by the actual proportion of the Trust's patients who registered at the closed GP. A 10km radius is a heuristic; actual registration overlap is superior.

### Mechanism Validation
The paper speculates that "patient absorption" explains the null result but offers no data to prove it. This is a key economic claim that requires evidence.
*   **Action:** Incorporate **GP Registration Data** (available monthly via NHS Digital). Show whether the patient lists of *surviving* practices in the same locality grew immediately following a closure. If surviving practices absorbed the patients, their list sizes should jump. If they did not, patients likely dispersed to A&E or unregistered care.
*   **Action:** Test the **111/UTC channel**. If patients are substituting away from A&E, they may be using Urgent Treatment Centres (UTCs). Include UTC attendance data as an alternative outcome to show whether demand shifted to secondary emergency care rather than major A&E.

### COVID De-trending and Parallel Trends
The post-COVID significance is the paper's most novel finding, but it is also the most fragile. The pandemic changed the *mean* level of A&E attendance drastically.
*   **Action:** Do not simply split the sample (Pre/Post). Use a **interaction model**: $\text{Closure}_{it} \times \text{PostCOVID}_{t}$. This allows you to test if the *marginal effect* of closure changed, holding the baseline trend constant.
*   **Action:** Plot the **event study coefficients** specifically for the post-2022 cohort. Ensure that pre-trends for trusts treated in 2023 are parallel to those treated in 2022. With universal treatment, this is hard; you may need to use **synthetic control methods** for the late-treated trusts to construct a valid counterfactual.

### Magnitude and Economic Interpretation
The claimed 6.6% increase translates to ~80,000 visits nationally. The cost calculation (£16 million) is plausible but simplistic.
*   **Action:** Refine the cost estimate. A&E costs vary by triage category (RCM codes). A GP closure might shift patients to minor injuries (SJR codes) rather than major resuscitation. Use **cost-per-attendance by triage category** to estimate the fiscal externality more accurately.
*   **Action:** Contextualize the magnitude. A 6.6% increase is large relative to the closure shock, but small relative to the overall post-COVID A&E surge (which was often >20%). Ensure the reader understands that this is a *marginal* effect on top of a massive baseline shift.

### Standard Errors and Inference
The paper uses clustered SEs at the trust level (122 clusters). This is appropriate for the panel dimension but does not fix the coefficient bias.
*   **Action:** Report **Bonhomme-Weidner** or **AKM** standard errors if using high-dimensional fixed effects.
*   **Action:** The Randomization Inference (RI) p-value (0.35) is useful for finite sample correction but does not validate the parallel trends assumption. Supplement RI with a **placebo test** using pseudo-closure dates generated from the empirical distribution of actual closures.

###
